-
Two families reflect on their malaria vaccine journey
It’s a sunny day in a rural subdivision of Lilongwe, Malawi. Seventeen-month-old Lusitana is playing outdoors with friends as her mother chats and laughs with neighbors. Just across the way, in another village, a young boy named Evision is also enjoying the end of the rainy season. Exactly one year...23 Apr 2020 -
Kenya strengthens fight against malaria with new vaccine
13 Sep 2019 -
A new tool for tricky vaccine development
Imagine if scientists could create their own antibodies – the protein that the immune system creates in order to fight diseases. While it might sound like something out of a science fiction novel, scientists have figured out a way to do it.25 Oct 2018 -
The challenges of malaria vaccine “challenge” trials: mosquitoes travel in business class to infect American volunteers—but fare better in economy
VMP001 Q&A with Ashley Birkett The director of the PATH Malaria Vaccine Initiative, Dr. Ashley Birkett, tells us about recently completed work on a novel vaccine approach against the “other malaria parasite,” Plasmodium vivax, and gives us a behind-the-scenes look at some unique hurdles to...22 Jun 2016 -
Searching for immune correlates in malaria vaccine development
MVI’s Scientific Advisor Ulrike (Ulli) Wille-Reece, an immunologist by training, recently sat down with Kenzie Tynuv of the communications team to discuss the search for immune correlates in the context of developing malaria vaccines. Prior to joining MVI, Ulli worked at the Vaccine Research Center...26 Jan 2016 -
Interview with Rick King, MVI Director of R&D
Rick King, PhD, joined the PATH Malaria Vaccine Initiative (MVI) in May 2014 as director of research and development (R&D) and head of the transmission-blocking vaccine (TBV) priority area, one of two areas of focus for MVI.31 Dec 2014